NorthWest Biotherapeutics Inc (NWBO)

[Extremist223]

Where is your rationale for how they are developing an antigen library?

Even though I think ARGS has a better shot, the more I think of it the less it really matters over all. Especially considering Doc Logic's points.

If companies are waiting for completely enriched off the shelf peptide vaccines covering all mutations, in order that they might conquer all cancer, they should really pursue NWBO, because that is where the pool of information for enrichment is being developed.